- Home
- KLXE vs GNTA Comparison
KLXE vs GNTA Comparison
Compare KLXE & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLXE
- GNTA
- Stock Information
- Founded
- KLXE 2018
- GNTA 2014
- Country
- KLXE United States
- GNTA Italy
- Employees
- KLXE N/A
- GNTA N/A
- Industry
- KLXE Oilfield Services/Equipment
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KLXE Energy
- GNTA Health Care
- Exchange
- KLXE Nasdaq
- GNTA Nasdaq
- Market Cap
- KLXE 90.4M
- GNTA 67.4M
- IPO Year
- KLXE N/A
- GNTA 2021
- Fundamental
- Price
- KLXE $4.51
- GNTA $5.34
- Analyst Decision
- KLXE Hold
- GNTA Strong Buy
- Analyst Count
- KLXE 1
- GNTA 1
- Target Price
- KLXE $4.50
- GNTA $25.00
- AVG Volume (30 Days)
- KLXE 92.5K
- GNTA 28.4K
- Earning Date
- KLXE 11-04-2024
- GNTA 01-01-0001
- Dividend Yield
- KLXE N/A
- GNTA N/A
- EPS Growth
- KLXE N/A
- GNTA N/A
- EPS
- KLXE N/A
- GNTA N/A
- Revenue
- KLXE $769,700,000.00
- GNTA N/A
- Revenue This Year
- KLXE N/A
- GNTA N/A
- Revenue Next Year
- KLXE $3.17
- GNTA N/A
- P/E Ratio
- KLXE N/A
- GNTA N/A
- Revenue Growth
- KLXE N/A
- GNTA N/A
- 52 Week Low
- KLXE $4.18
- GNTA $2.20
- 52 Week High
- KLXE $12.13
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- KLXE 33.44
- GNTA 56.89
- Support Level
- KLXE $4.31
- GNTA $4.89
- Resistance Level
- KLXE $4.59
- GNTA $6.20
- Average True Range (ATR)
- KLXE 0.31
- GNTA 0.70
- MACD
- KLXE -0.05
- GNTA -0.06
- Stochastic Oscillator
- KLXE 8.92
- GNTA 37.32
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.